medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2012, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2012; 57 (1)

Deep brain stimulation in Parkinson´s disease. First case treated at the ABC Neurological Center

Martínez-Hernández HR, Arellano-Reynoso A

Language: Spanish
References: 28
Page: 53-61
PDF size: 128.15 Kb.


ABSTRACT

Parkinson’s disease is one of the most important neurodegenerative disorders because it’s increasing prevalence, but mainly it’s in relation with the major limitation in activities of daily life. The progression of this disease affects the motor skills of patients, and although the therapeutic possibilities have been increasing in the last 40 years, the onset of drug induce complications limit its usefulness and effectiveness in the short time. The possibility of a surgical treatment using Deep Brain Stimulation has allowed broaden the treatment horizon, limit the drug induce complications, and increase the functional capacity of the patients. In our country only few tertiary centers have specialized teams for the use of this new treatment option. We report the first case treated at the Neurological Center of the ABC Medical Center with Deep Brain Stimulation of the subthalamic nucleus in a patient with advanced disease and disabling dyskinesias that obtained an important clinical improvement to recover his routine activities with excellent quality of life. With this case presentation we describe the technical features of the procedure, main criteria for patient selection and the clinical experience in different centers around the world.


REFERENCES

  1. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-376.

  2. De Lau LM, Breteler MMB. Epidemiology of Parkinson’s disease. Lancet Neurol 2006; 5: 525-535.

  3. Walter BL, Vitek JL. Surgical treatment for Parkinson’s disease. Lancet Neurol 2004; 3: 719-728.

  4. Benabid AL, Deuschl G, Lang AE, Lyons KE, Rezai AR. Deep brain stimulation for Parkinson’s disease. Mov Disord 2006; 21 (Suppl 14): S168-S170.

  5. Sydow O. Parkinson’s disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion. FEBS J 2008; 275: 1370-1376.

  6. Movement Disorder Society Task Force on Rating Scales for Parkinson’s disease. UPDRS: status and recommendations. Mov Disord 2003; 18: 738-750.

  7. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. Mov Disord 2004; 19 (9): 1020-1028.

  8. Defer GL, Widner H, Marié RM, Rémy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD). Mov Disord 1999; 14(4): 572-584.

  9. Rodríguez RL, Fernández HH, Haq I, Okun MS. Pearls in patient selection for deep brain stimulation. Neurologist 2007; 13: 253-260.

  10. Lang AE y Widner H. Deep Brain Stimulation for Parkinson’s disease: patient selection and evaluation. Mov Disord 2002; 17 (Suppl 3): S94-S101.

  11. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R, Poewe W, Tröster AI, Uitti R, Vonn V. Deep brain stimulation: preoperative Issues. Mov Disord 2006; 21 (Suppl 14): S171-S196.

  12. Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart, Hallet M, Miyasaki J, Stevens J, Weiner WJ. Practice parameter: treatment of Parkinson disease with motor fluctuation and diskinesia (an evidence-based review). Neurology 2006; 66: 983-995.

  13. Tarsy D, Vitek JL, Lozano AM. Methods of programming and patient management with deep brain stimulation en surgical treatment of Parkinson’s disease and other movement disorders. Humana Press 2003; 14: 189-211.

  14. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. A randomized controlled trial. JAMA 2009; 301 (1): 63-73.

  15. Lozano AM, Snyder BJ. Deep brain stimulation for parkinsonian gait disorders. J Neurol 2008; 205 (Suppl 4): 30-31.

  16. Welter ML, Houeto JL, Montcel T, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Clinical predictive factors of subtalamic stimulation in Parkinson’s disease. Brain 2002; 125: 575-583.

  17. Mazzone P, Lozano A, Stanzione P, Galati S, Scarnati E, Peppe A, Stefani A. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport 2005; 16 (17): 1877-1881.

  18. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport 2005; 16 (17): 1883-1887.

  19. Rodríguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004; 75 (10): 1382-1385.

  20. Houeto JL. Welter ML, Bejjani PB, Tezenas, du Montcel ST, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease. Intraoperative predictive factors. Arch Neurol 2003; 60: 690-694.

  21. Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ. Implantation of deep brain stimulators into subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002; 97: 370-387.

  22. Sterio D, Zonenshayn M, Mogilner AY, Kiprovski K, Kelly PJ, Beric A. Neurophysiological refinement of subthalamic nucleus targeting. Neurosurgery 2002; 50: 58-69.

  23. Gross RE, Krack P, Rodríguez-Oroz M, Rezai AR, Benabid AL. Electrophysiological mapping for the implantation of deep brain stimulation for Parkinson’s disease and tremor. Mov Disord 2006; 21 (Suppl 14): S259-S283.

  24. Temel Y, Wilbrink P, Dutis A, Boon P, Tromp S, Ackermans L, van Kranen-Mastenboek V, Weber W, Visser-Vandewalle V. Single electrode and multiple electrodes guided electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. Neurosurgery 2007; 61 (ONS Suppl 2): ONS346-ONS357.

  25. Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE, Rodríguez-Oroz M, Tamma F, Tröster AI, Vitek JL, Volkmann J, Voon V. Deep brain stimulation: postoperative issues. Mov Disord 2006; 21 (Suppl 14): S219-S237.

  26. Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson’s disease. Mov Disord 2006; 21 (Suppl 14): S284-S289.

  27. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE y Deuschl G. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (Suppl 14): S290-S302.

  28. Voon V, Kubu C, Krack P, Houeto JL, Tröster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21 (Suppl 14): S305-S326. 




2020     |     www.medigraphic.com